Chinese Japanese Germany Korea

Thalidomide-4-NH-C7-COO(t-Bu)

Thalidomide-4-NH-C7-COO(t-Bu) Structure
Thalidomide-4-NH-C7-COO(t-Bu) structure
CAS No.
2226139-39-3
Chemical Name:
Thalidomide-4-NH-C7-COO(t-Bu)
Synonyms
Thalidomide-4-NH-C7-COO(t-Bu);2-(2,6-Dioxohexahydropyridin-3-yl)-4-(octylamino)isoindole-1,3-dione;tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoate;tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propanoate;Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester
CBNumber:
CB413888925
Molecular Formula:
C25H33N3O6
Molecular Weight:
471.55
MDL Number:
MOL File:
2226139-39-3.mol
Last updated:2025-05-19 13:47:41
Request For Quotation

Thalidomide-4-NH-C7-COO(t-Bu) Properties

Boiling point 665.374±55.00 °C(Press: 760.00 Torr)(predicted)
Density 1.253±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka 10.748±0.40(predicted)

Thalidomide-4-NH-C7-COO(t-Bu) Preparation Products And Raw materials

Raw materials

Preparation Products

Thalidomide-4-NH-C7-COO(t-Bu) Suppliers

Global Suppliers ( 4)
Supplier Tel Email Country ProdList Advantage
Daicel Chiral Technologies (China)CO.,LTD 021-50460086-9 15921403865 han_yajun@dctc.daicel.com China 7915 65
Shanghai Hongboshangyi Pharmaceutical Technology Co. , Ltd. 15927323052 shenqianyan@prssh.com China 228 58
Jilin Chinese Academy of Sciences-yanshen Technology 18143011203 ET-market@chemextension.com China 38921 58
Jilin Chinese Academy of Sciences-yanshen Technology 18143011203 info@chemextension.com China 42052 58
Supplier Advantage
Daicel Chiral Technologies (China)CO.,LTD 65
Shanghai Hongboshangyi Pharmaceutical Technology Co. , Ltd. 58
Jilin Chinese Academy of Sciences-yanshen Technology 58
Jilin Chinese Academy of Sciences-yanshen Technology 58

2226139-39-3 (Thalidomide-4-NH-C7-COO(t-Bu)) Related Search:

tert-butyl (5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentyl)carbamate Thalidomide Thalidomide-4-NH-C7-NH-Boc Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester Thalidomide-4-O-C3-NHBoc
3-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)propanoic acid Thalidomide-4-NH-C9-NH-Boc Propanoic acid, 3-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]-, 1,1-dimethylethyl ester 5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, Hexanoic acid, 6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester
Nonanoic acid, 9-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, 1,1-dimethylethyl ester 6-Bromo-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)hexanamide

1of3

Thalidomide-4-NH-C7-COO(t-Bu) tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoate 2-(2,6-Dioxohexahydropyridin-3-yl)-4-(octylamino)isoindole-1,3-dione Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propanoate 2226139-39-3